How your sponsorship helps
As the premier Australasian body for radiotherapy research, TROG aims to improve quality of life for all cancer patients that utilise radiotherapy as part of their treatment. There are many types of cancers that can be treated with radiotherapy such as breast, lung, prostate, skin, head and neck, gynaecological and gastrointestinal.
With your support TROG is able to build on its formidable research record. Since 1989, TROG has launched more than 90 clinical trials with more than 14,000 cancer patients taking part.
We currently need funding to initiate research
When a radiation oncologist or other TROG researcher has an idea for a study, there are several processes that must occur before it can begin. This first year is referred to as a 'trial in development' and includes such activities as forming the trial protocol; ethics review; and peer review. In many ways this period is the most critical to the success of a trial, yet is not covered by government funding. Please contact us if you wish for your donation to support this critical part of the research process.
Where your donation currently helps
Your donation helps TROG fulfil many daily research activities, including:
- ensuring patient safety is monitored
- developing protocols for our researchers
- arranging ongoing peer review
- developing Quality Assurance requirements that will be applied continuously throughout the life of the trial
- ensuring all the indemnity, contractual and regulatory documentation for a trial is complete
- preparing all record keeping documents and setting up a records database
- ensuring a trial complies with strict international Good Clinical Practice standards
- ensuring patient recruitment and data collection targets are being met
- ensuring data is being collated and primary/final endpoints are reported
- reporting timelines to regulatory agencies
Cancer research projects you can help fund now
TROG also undertakes other projects that support the running of clinical trials; below is an example for which we are currently seeking funding.
Post recruitment analysis
TROG is reliant on support received from major funding bodies such as Cancer Australia for the development and conduct phase of trials.
Generating funding for analysis and patient follow-ups, however, is difficult. Follow-ups are vital as they allow patients to be monitored by their radiation oncologist for 2, 5, 10 and 20 years after their trial treatment period has ended. Many patients see this as one of the benefits of taking part in a clinical trial since it provides substantial care. Please let us know if you would like your donation to be directed toward this beneficial process for patients.